CA1104929A - Preparations pharmaceutiques de lactobacilles - Google Patents

Preparations pharmaceutiques de lactobacilles

Info

Publication number: CA1104929A
Authority: CA; Canada
Prior art keywords: strains; lactobacillus; substances; composition; medium
Prior art date: 1977-08-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA285,595A

Other languages

English (en)

Inventor

Kosei Hata

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SEIKEN KAI FOUNDATIONAL JURIDICAL PERSON

Original Assignee

SEIKEN KAI FOUNDATIONAL JURIDICAL PERSON

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-08-26

Filing date

1977-08-26

Publication date

1981-07-14

1977-08-26 Application filed by SEIKEN KAI FOUNDATIONAL JURIDICAL PERSON filed Critical SEIKEN KAI FOUNDATIONAL JURIDICAL PERSON

1977-08-26 Priority to CA285,595A priority Critical patent/CA1104929A/fr

1981-07-14 Application granted granted Critical

1981-07-14 Publication of CA1104929A publication Critical patent/CA1104929A/fr

Status Expired legal-status Critical Current

Links

241000186660 Lactobacillus Species 0.000 title claims abstract description 74
229940039696 lactobacillus Drugs 0.000 title claims abstract description 74
238000002360 preparation method Methods 0.000 title abstract description 62
208000015181 infectious disease Diseases 0.000 claims abstract description 9
230000003115 biocidal effect Effects 0.000 claims abstract description 6
235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 6
229930195729 fatty acid Natural products 0.000 claims abstract description 6
239000000194 fatty acid Substances 0.000 claims abstract description 6
150000004665 fatty acids Chemical class 0.000 claims abstract description 6
238000004519 manufacturing process Methods 0.000 claims abstract description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 27
239000000126 substance Substances 0.000 claims description 20
239000011782 vitamin Substances 0.000 claims description 18
229940088594 vitamin Drugs 0.000 claims description 18
235000013343 vitamin Nutrition 0.000 claims description 17
229930003231 vitamin Natural products 0.000 claims description 17
239000002253 acid Substances 0.000 claims description 14
239000000203 mixture Substances 0.000 claims description 12
229910052979 sodium sulfide Inorganic materials 0.000 claims description 11
229910021529 ammonia Inorganic materials 0.000 claims description 9
210000000941 bile Anatomy 0.000 claims description 8
208000035473 Communicable disease Diseases 0.000 claims description 7
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
230000000813 microbial effect Effects 0.000 claims description 4
229910000069 nitrogen hydride Inorganic materials 0.000 claims description 4
ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 claims description 4
230000001580 bacterial effect Effects 0.000 claims description 3
239000003899 bactericide agent Substances 0.000 claims description 3
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 3
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 3
239000002504 physiological saline solution Substances 0.000 claims description 3
-1 C6H9N Chemical compound 0.000 claims description 2
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims description 2
238000001816 cooling Methods 0.000 claims description 2
239000000546 pharmaceutical excipient Substances 0.000 claims 3
GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 claims 2
LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims 1
239000003883 ointment base Substances 0.000 claims 1
229940074386 skatole Drugs 0.000 claims 1
201000010099 disease Diseases 0.000 abstract description 39
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 39
244000052616 bacterial pathogen Species 0.000 abstract description 26
230000001717 pathogenic effect Effects 0.000 abstract description 14
230000008961 swelling Effects 0.000 abstract description 14
208000014617 hemorrhoid Diseases 0.000 abstract description 12
230000001225 therapeutic effect Effects 0.000 abstract description 11
206010061218 Inflammation Diseases 0.000 abstract description 9
230000004054 inflammatory process Effects 0.000 abstract description 9
208000034693 Laceration Diseases 0.000 abstract description 8
208000004232 Enteritis Diseases 0.000 abstract description 6
208000007882 Gastritis Diseases 0.000 abstract description 5
206010003011 Appendicitis Diseases 0.000 abstract description 4
206010028741 Nasal inflammation Diseases 0.000 abstract description 3
239000000825 pharmaceutical preparation Substances 0.000 abstract description 3
239000004480 active ingredient Substances 0.000 abstract description 2
239000002207 metabolite Substances 0.000 abstract description 2
239000002609 medium Substances 0.000 description 43
241000894006 Bacteria Species 0.000 description 37
235000016709 nutrition Nutrition 0.000 description 32
239000003242 anti bacterial agent Substances 0.000 description 30
229940088710 antibiotic agent Drugs 0.000 description 29
230000000694 effects Effects 0.000 description 14
238000002474 experimental method Methods 0.000 description 14
230000000968 intestinal effect Effects 0.000 description 13
239000003814 drug Substances 0.000 description 11
229940079593 drug Drugs 0.000 description 11
150000007513 acids Chemical class 0.000 description 10
238000007792 addition Methods 0.000 description 10
150000001413 amino acids Chemical class 0.000 description 10
208000002193 Pain Diseases 0.000 description 9
210000004027 cell Anatomy 0.000 description 9
VDQVEACBQKUUSU-UHFFFAOYSA-M disodium;sulfanide Chemical compound [Na+].[Na+].[SH-] VDQVEACBQKUUSU-UHFFFAOYSA-M 0.000 description 9
230000036407 pain Effects 0.000 description 9
208000024891 symptom Diseases 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 8
239000000463 material Substances 0.000 description 8
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
206010036790 Productive cough Diseases 0.000 description 7
230000003110 anti-inflammatory effect Effects 0.000 description 7
210000003802 sputum Anatomy 0.000 description 7
208000024794 sputum Diseases 0.000 description 7
235000000346 sugar Nutrition 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
150000001875 compounds Chemical class 0.000 description 6
239000000284 extract Substances 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
210000000936 intestine Anatomy 0.000 description 6
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
238000000034 method Methods 0.000 description 6
230000035764 nutrition Effects 0.000 description 6
229920001817 Agar Polymers 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
241000282414 Homo sapiens Species 0.000 description 5
239000008272 agar Substances 0.000 description 5
230000000844 anti-bacterial effect Effects 0.000 description 5
239000012530 fluid Substances 0.000 description 5
239000008103 glucose Substances 0.000 description 5
230000000877 morphologic effect Effects 0.000 description 5
235000015097 nutrients Nutrition 0.000 description 5
238000012360 testing method Methods 0.000 description 5
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
208000033809 Suppuration Diseases 0.000 description 4
206010000269 abscess Diseases 0.000 description 4
230000000740 bleeding effect Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
238000004332 deodorization Methods 0.000 description 4
230000001877 deodorizing effect Effects 0.000 description 4
208000027866 inflammatory disease Diseases 0.000 description 4
230000002757 inflammatory effect Effects 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
239000002674 ointment Substances 0.000 description 4
210000003695 paranasal sinus Anatomy 0.000 description 4
201000009890 sinusitis Diseases 0.000 description 4
235000002639 sodium chloride Nutrition 0.000 description 4
238000006467 substitution reaction Methods 0.000 description 4
150000008163 sugars Chemical class 0.000 description 4
229910052717 sulfur Inorganic materials 0.000 description 4
210000001215 vagina Anatomy 0.000 description 4
208000035143 Bacterial infection Diseases 0.000 description 3
241000282472 Canis lupus familiaris Species 0.000 description 3
239000001888 Peptone Substances 0.000 description 3
108010080698 Peptones Proteins 0.000 description 3
206010039101 Rhinorrhoea Diseases 0.000 description 3
239000004098 Tetracycline Substances 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
208000022362 bacterial infectious disease Diseases 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
235000013409 condiments Nutrition 0.000 description 3
238000000605 extraction Methods 0.000 description 3
230000036541 health Effects 0.000 description 3
239000004310 lactic acid Substances 0.000 description 3
235000014655 lactic acid Nutrition 0.000 description 3
244000005700 microbiome Species 0.000 description 3
210000000214 mouth Anatomy 0.000 description 3
208000010753 nasal discharge Diseases 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
235000019319 peptone Nutrition 0.000 description 3
231100000614 poison Toxicity 0.000 description 3
230000007096 poisonous effect Effects 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
238000011084 recovery Methods 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
229960002180 tetracycline Drugs 0.000 description 3
229930101283 tetracycline Natural products 0.000 description 3
235000019364 tetracycline Nutrition 0.000 description 3
150000003522 tetracyclines Chemical class 0.000 description 3
241000304886 Bacilli Species 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
241000607142 Salmonella Species 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
230000002579 anti-swelling effect Effects 0.000 description 2
210000000436 anus Anatomy 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
210000000416 exudates and transudate Anatomy 0.000 description 2
210000003495 flagella Anatomy 0.000 description 2
208000035474 group of disease Diseases 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000007794 irritation Effects 0.000 description 2
235000013372 meat Nutrition 0.000 description 2
210000004400 mucous membrane Anatomy 0.000 description 2
150000002823 nitrates Chemical class 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
125000002924 primary amino group Chemical class [H]N([H])* 0.000 description 2
235000019419 proteases Nutrition 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
239000011593 sulfur Substances 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
ZUXNHFFVQWADJL-UHFFFAOYSA-N 3,4,5-trimethoxy-n-(2-methoxyethyl)-n-(4-phenyl-1,3-thiazol-2-yl)benzamide Chemical compound N=1C(C=2C=CC=CC=2)=CSC=1N(CCOC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 ZUXNHFFVQWADJL-UHFFFAOYSA-N 0.000 description 1
240000003291 Armoracia rusticana Species 0.000 description 1
235000011330 Armoracia rusticana Nutrition 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
XPHQBTAVNWSKPM-FAOVPRGRSA-N CCC(O)=O.CCCC(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O Chemical compound CCC(O)=O.CCCC(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XPHQBTAVNWSKPM-FAOVPRGRSA-N 0.000 description 1
240000004160 Capsicum annuum Species 0.000 description 1
235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
235000007862 Capsicum baccatum Nutrition 0.000 description 1
102000016938 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
206010009137 Chronic sinusitis Diseases 0.000 description 1
241000543381 Cliftonia monophylla Species 0.000 description 1
206010010774 Constipation Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
241001517310 Eria Species 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
241000400085 Hemorrhois Species 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
201000008197 Laryngitis Diseases 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
208000003286 Protein-Energy Malnutrition Diseases 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
201000004328 Pulpitis Diseases 0.000 description 1
206010037464 Pulpitis dental Diseases 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
231100000403 acute toxicity Toxicity 0.000 description 1
230000002411 adverse Effects 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
238000009412 basement excavation Methods 0.000 description 1
230000006399 behavior Effects 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000037396 body weight Effects 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001728 capsicum frutescens Substances 0.000 description 1
239000002775 capsule Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000035606 childbirth Effects 0.000 description 1
208000037976 chronic inflammation Diseases 0.000 description 1
208000037893 chronic inflammatory disorder Diseases 0.000 description 1
208000027157 chronic rhinosinusitis Diseases 0.000 description 1
231100000160 chronic toxicity Toxicity 0.000 description 1
230000007665 chronic toxicity Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
235000021438 curry Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
229960003067 cystine Drugs 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
229910000388 diammonium phosphate Inorganic materials 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000035622 drinking Effects 0.000 description 1
238000001035 drying Methods 0.000 description 1
208000001848 dysentery Diseases 0.000 description 1
KOWWOODYPWDWOJ-LVBPXUMQSA-N elatine Chemical compound C([C@]12CN(C3[C@@]45OCO[C@]44[C@H]6[C@@H](OC)[C@@H]([C@H](C4)OC)C[C@H]6[C@@]3([C@@H]1[C@@H]5OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N1C(=O)CC(C)C1=O KOWWOODYPWDWOJ-LVBPXUMQSA-N 0.000 description 1
230000002550 fecal effect Effects 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
208000007565 gingivitis Diseases 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
238000011835 investigation Methods 0.000 description 1
229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
206010026820 marasmus Diseases 0.000 description 1
QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
230000004899 motility Effects 0.000 description 1
239000006872 mrs medium Substances 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
231100000255 pathogenic effect Toxicity 0.000 description 1
150000002960 penicillins Chemical class 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
ABBQGOCHXSPKHJ-WUKNDPDISA-N prontosil Chemical compound NC1=CC(N)=CC=C1\N=N\C1=CC=C(S(N)(=O)=O)C=C1 ABBQGOCHXSPKHJ-WUKNDPDISA-N 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
229940120668 salicin Drugs 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
238000010517 secondary reaction Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
238000009958 sewing Methods 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
235000020183 skimmed milk Nutrition 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
231100000456 subacute toxicity Toxicity 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000003464 sulfur compounds Chemical class 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Landscapes

Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA285,595A 1977-08-26 1977-08-26 Preparations pharmaceutiques de lactobacilles Expired CA1104929A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA285,595A CA1104929A (fr)	1977-08-26	1977-08-26	Preparations pharmaceutiques de lactobacilles

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA285,595A CA1104929A (fr)	1977-08-26	1977-08-26	Preparations pharmaceutiques de lactobacilles

Publications (1)

Publication Number	Publication Date
CA1104929A true CA1104929A (fr)	1981-07-14

Family

ID=4109416

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA285,595A Expired CA1104929A (fr)	1977-08-26	1977-08-26	Preparations pharmaceutiques de lactobacilles

Country Status (1)

Country	Link
CA (1)	CA1104929A (fr)

1977
- 1977-08-26 CA CA285,595A patent/CA1104929A/fr not_active Expired

Legal Events

Date	Code	Title	Description
1998-07-14	MKEX	Expiry

Publication	Publication Date	Title
US4314995A (en)	1982-02-09	Pharmaceutical lactobacillus preparations
US4871539A (en)	1989-10-03	Biodeodorizer and process for preparing same
KR0123456B1 (ko)	1997-11-19	프로바이오틱 균
KR101228993B1 (ko)	2013-02-01	발효 및 배양 방법, 식물발효 엑기스, 식물발효 엑기스분말 및 이 식물발효 엑기스 배합물
CN115607577B (zh)	2024-01-30	一种具有缓解口腔炎症功效的益生菌剂及其制备方法和应用
JP2019526258A (ja)	2019-09-19	脱毛症防止、発毛促進または性機能改善能を有するリューコノストック・ホルザプフェリイ菌株及びこれを含む組成物
AU624356B2 (en)	1992-06-11	Bacterial preparation for prophylaxis and treatment of inflammatory processes and allergic diseases
US5705152A (en)	1998-01-06	Antimicrobial composition
JP4193269B2 (ja)	2008-12-10	新規な生体浄化活性型乳酸菌製剤
Rotstein et al.	1985	Lethal microbial synergism in intra-abdominal infections: Escherichia coli and Bacteroides fragilis
RU2264453C2 (ru)	2005-11-20	Биопрепарат "ирилис" ветеринарного назначения
AU2004261832B2 (en)	2007-10-04	Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
JP6506259B2 (ja)	2019-04-24	シュードアルテロモナス（Ｐｓｅｕｄｏａｌｔｅｒｏｍｏｎａｓ）属由来の単離された細菌の使用、シクロリポペプチド、及びその使用
JP2023518928A (ja)	2023-05-09	バイオフィルムの形成を妨害する為の且つバイオフィルム関連障害を処置する為の組成物
AU650684B2 (en)	1994-06-30	Antimicrobial composition
CA1104929A (fr)	1981-07-14	Preparations pharmaceutiques de lactobacilles
RU2119796C1 (ru)	1998-10-10	Комплексный пробиотический препарат для животных "бифитрилак"
GB1585863A (en)	1981-03-11	Pharmaceutical lactobacillus preparations
Rosenberg et al.	1984	Antibiotic TA: an adherent antibiotic
CN107095061A (zh)	2017-08-29	提高育肥猪肠道屏障功能的发酵饲料制备方法及其应用
EP1389464A1 (fr)	2004-02-18	Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon
DE2738652A1 (de)	1979-03-15	Lactobacillus-praeparat und seine verwendung zur behandlung bakterieller infektionen
CN107467670B (zh)	2020-12-01	一种益生菌制剂及其制备方法与应用
Friedberger et al.	1904	Friedberger & Fröhner's Veterinary Pathology: Authorised Translation
RU2377005C1 (ru)	2009-12-27	Способ лечения желудочно-кишечных болезней у телят